City of Hope's mission is to deliver cures of tomorrow to the people who need them today. Founded in 1913, City of Hope has grown into one of the largest cancer research and treatment organizations in the U.S. and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center as its core, City of Hope brings a uniquely integrated model to patients spanning cancer care, research, and development, academics and training, and innovative initiatives. City of Hope's growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer center in Orange County, California, and treatment facilities in Atlanta, Chicago, and Phoenix. City of Hope's affiliate family of organizations includes Translational Genomics Research Institute, and AccessHope™. For more information about City of Hope, follow us on Facebook, Twitter, YouTube,  Instagram, or LinkedIn.